Difference between revisions of "Neuroendocrine tumors future or investigational therapies"
|Line 12:||Line 12:|
Revision as of 19:41, 26 August 2015
Neuroendocrine tumors Microchapters
Future or Investigational Therapies
Therapies based on growth factor inhibitors are in the experimental stage. These inhibitors of epidermal growth factor receptors (EGFRs), of vascular endothelial growth factor receptors (VEGFRs), and of angiopoietin-related growth factor (AGF) include imatinib, sunitinib, temozolide, thalidomide, sorafenib, and panitumumab.